FilingSEC EDGAR6-K
Biodexa Pharmaceuticals Announces ADS Ratio Change Equivalent to 1-for-8 Reverse Split
· SEC accepted
StagePending
Filing content
The company is changing its ADS ratio from 1:50 to 1:400, effective on or about October 26, 2026, which is equivalent to a 1-for-8 reverse ADS split.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…